Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-451

This text appears to be a description of a medication called Mitomycin. It contains 5 mg of Mitomycin and 10 mg of mannitol. The usual dosage and additional information can be found in the package insert. The storage instructions mention retaining the container in the carton and storing the dry powder at a temperature range of 15°C to 30°C, protected from light. The reconstituted solution should be stored in the refrigerator at a temperature of 2°C to 8°C and discarded after 14 days if refrigerated, or after 7 days if unrefrigerated. The text also includes some additional information about administration and discarding unused portions.*

This is a description of a medication called Mitomycin for Injection, USP. It is mentioned that the medication must be administered intravenously to avoid tissue damage. The medication is cytotoxic and requires special handling procedures, which can be found in the insert provided. The medication is contained in a single-dose vial and any unused portion should be discarded. The vial contains 5mg of mitomycin, USP, and 10mg of mannitol. Instructions are provided to add 10mL of sterile water for injection, USP, to dissolve the product. The reconstituted solution will contain 0.5mg of mitomycin, USP, and have a pH between 6.0 and 8.0. The usual dosage information can be found in the package insert. The medication should be stored at room temperature or refrigerated between 2°C and 8°C. After reconstitution, the solution should be protected from light and stored under refrigeration. The medication is distributed by Euga US LG and manufactured in India. The provided text includes warnings and cautions about the administration and handling of the medication.*

This vial contains mitomycin, USP 20 mg and mannitol 40 mg. It is manufactured in India for sterile water for injection. To use, add 40 mL of sterile water for injection and shake to dissolve. If the product does not dissolve immediately, allow it to stand at room temperature until a solution is obtained. Each mL of the reconstituted solution will contain 0.5 mg of mitomycin, USP and has a pH between 6.0 and 8.0. The usual dosage should be determined based on the package insert. This medication must be administered intravenously to avoid tissue damage. The vial should be stored at 25°C, protected from light, and should not be exposed to excessive heat. The reconstituted solution should also be protected from light and stored under refrigeration between 2° and 8°C. Unused portion of the solution should be discarded after 14 days if refrigerated or after 7 days if unrefrigerated.*

This is a description of a medication called Mitomycin, which is available in a single-dose vial. The vial contains 40 mg of Mitomycin and 80 mg of Mannitol. To prepare the medication, 80 mL of Sterile Water needs to be added and the vial should be shaken to dissolve the components. The reconstituted solution will contain 0.5 mg of Mitomycin per mL and should have a pH between 6.0 and 8.0. The medication should be administered intravenously to avoid tissue damage and any unused portion of the medication should be discarded. The dosage instructions and full prescribing information can be found in the package insert. The medication should be stored in the original container, at a temperature between 15°C and 30°C, protected from light. The reconstituted solution should also be protected from light and stored under refrigeration between 2°C and 8°C. After reconstitution, the solution should be discarded after 14 days if refrigerated or after 7 days if not refrigerated. The manufacturer of this medication is Eugia USLLC, and their address is in Windsor, I 08520. The text also includes some unreadable characters, and it ends with the word "Plassee".*

This is a description for a medication called Mitomycin for Injection. It is a cytotoxic drug that must be administered intravenously to avoid tissue damage. The medication is supplied in single-dose vials containing 40 mg of Mitomycin and 80 mg of mannitol. To prepare the medication, 80 mL of sterile water for injection should be added to the vial and shaken to dissolve. If the product does not dissolve immediately, it should be allowed to stand at room temperature until a solution is obtained. Each mL of the reconstituted solution will contain 0.5 mg of Mitomycin and have a pH between 6.0 and 8.0. The usual dosage should be determined based on the package insert. The storage instructions state that the dry powder should be stored at 25°C, with excursions permitted between 15°C and 30°C, protected from light. The reconstituted solution should also be protected from light and stored under refrigeration between 2°C and 8°C. It should be discarded after 14 days if refrigerated, or after 7 days if left unrefrigerated. The vial stopper does not contain natural rubber latex. The medication is distributed by Eugia US LLC and was made in India. The provided code is: TS/DRUGS/24/2015.*